Stephanie Gaillard

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Novartis
    Date added: 
    08/29/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    NRG
    Date added: 
    08/29/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Tempest
    Date added: 
    08/29/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Tesaro/GSK
    Date added: 
    08/29/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    UptoDate
    Date added: 
    08/29/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Verastem
    Date added: 
    08/29/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond